Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells

Journal of Immunology

Volumn 171, Issue 3, 2003, Pages 1172-1182

  Strauss, Gudrun ^a   Knape, Ingrid ^a   Melzner, Ingo ^b   Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 10; CASPASE 3; CASPASE 8; CD95 RECEPTOR; FAS ANTIGEN; HLA A1 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CELL SURFACE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE ESCAPE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE DEPLETION; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SENSITIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TECHNIQUE; TISSUE DEGENERATION;

EID: 0041845182     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.3.1172     Document Type: Article

References (67)

1. Smith, C. A., G. T. Williams, R. Kingston, E. J. Jenkinson, and J. J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181.
2. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245.
3. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
4. Dhein, J., H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
5. Stassi, G., and R. De Maria. 2002. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2:195.
6. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1:469.
7. Wang, J., L. Zheng, A. Lobito, F. K. Chan, J. Dale, M. Sneller, X. Yao, J. M. Puck, S. E. Straus, and M. J. Lenardo. 1999. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98:47.
8. Bleesing, J. J., M. R. Brown, S. E. Straus, J. K. Dale, R. M. Siegel, M. Johnson, M. J. Lenardo, J. M. Puck, and T. A. Fleisher. 2001. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 98:2466.
9. Kischkel, F. C., D. A. Lawrence, A. Tinel, H. LeBlanc, A. Virmani, P. Schow, A. Gazdar, J. Blenis, D. Arnott, and A. Ashkenazi. 2001. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276:46639.
10. Algeciras-Schimnich, A., L. Shen, B. C. Barnhart, A. E. Murmann, J. K. Burkhardt, and M. E. Peter. 2002. Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22:207.
11. Yang, X., H. Y. Chang, and D. Baltimore. 1998. Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell. 1:319.
12. Kirchhoff, S., W. W. Muller, A. Krueger, I. Schmitz, and P. H. Krammer. 2000. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165:6293.
13. Varadhachary, A. S., M. E. Peter, S. N. Perdow, P. H. Krammer, and P. Salgame. 1999. Selective up-regulation of phosphatidylinositol 3′-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. J. Immunol. 163:4772.
14. Jones, R. G., A. R. Elford, M. J. Parsons, L. Wu, C. M. Krawczyk, W. C. Yeh, R. Hakem, R. Rottapel, J. R. Woodgett, and P. S. Ohashi. 2002. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J. Exp. Med. 196:335.
15. Semra, Y. K., O. A. Seidi, and M. K. Sharief. 2001. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J. Neuroimmunol. 113:268.
16. Sharief, M. K., and Y. K. Semra. 2001. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 119:358.
17. Waase, I., C. Kayser, P. J. Carlson, J. J. Goronzy, and C. M. Weyand. 1996. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum. 39:904.
18. - T cells from rheumatoid arthritis patients. J. Immunol. 161:1018.
19. null T cells are associated with defects in apoptotic pathways. J. Immunol. 165:6301.
20. null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 165:1138.
21. Hamann, D., P. A. Baars, M. H. Rep, B. Hooibrink, S. R. Kerkhof-Garde, M. R. Klein, and R. A. van Lier. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186:1407.
22. + T cells from a memory to memory/effector phenotype. J. Immunol. 168:5538.
23. + T cell response. J. Immunol. 168:5455.
24. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708.
25. Strauss, G., W. Osen, and K. M. Debatin. 2002. Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin. Exp. Immunol. 128:255.
26. Hochman, J. H., Y. Shimizu, R. DeMars, and M. Edidin. 1988. Specific associations of fluorescent β-2-microglobulin with cell surfaces: the affinity of different H-2 and HLA antigens for β-2-microglobulin. J. Immunol. 140:2322.
27. Zemmour, J., A. M. Little, D. J. Schendel, and P. Parham. 1992. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148:1941.
28. Pezzutto, A., B. Dorken, P. S. Rabinovitch, J. A. Ledbetter, G. Moldenhauer, and E. A. Clark. 1987. CD19 monoclonal antibody HD37 inhibits antiimmunoglobulin-induced B cell activation and proliferation. J. Immunol. 138:2793.
29. Carrera, A. C., F. Sanchez-Madrid, M. Lopez-Botet, C. Bernabeu, and M. O. De Landazuri. 1987. Involvement of the CD4 molecule in a post-activation event on T cell proliferation. Eur. J. Immunol. 17:179.
30. Hoffman, R. A., P. C. Kung, W. P. Hansen, and G. Goldstein. 1980. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc. Natl. Acad. Sci. USA 77:4914.
31. Trauth, B. C., C. Klas, A. M. Peters, S. Matzku, P. Moller, W. Falk, K. M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
32. + T cells closely correlates with CD56 surface expression. J. Immunol. 164:1148.
33. Holler, N., R. Zaru, O. Micheau, M. Thome, A. Attinger, S. Valitutti, J. L. Bodmer, P. Schneider, B. Seed, and J. Tschopp. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1:489.
34. Stambolic, V., A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J. M. Penninger, D. P. Siderovski, and T. W. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29.
35. Chan, T. O., S. E. Rittenhouse, and P. N. Tsichlis. 1999. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68:965.
36. Maehama, T., and J. E. Dixon. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:13375.
37. Ring, G. H., and F. G. Lakkis. 1999. Breakdown of self-tolerance and the pathogenesis of autoimmunity. Semin. Nephrol. 19:25.
38. Chatenoud, L., B. Salomon, and J. A. Bluestone. 2001. Suppressor T cells they're back and critical for regulation of autoimmunity! Immunol. Rev. 182:149.
39. Rathmell, J. C., and C. B. Thompson. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109(Suppl.):S97.
40. Spaner, D., K. Raju, B. Rabinovich, and R. G. Miller. 1999. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. J. Immunol. 162:1192.
41. Gorak-Stolinska, P., J. P. Truman, D. M. Kemeny, and A. Noble. 2001. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-α. J. Leukocyte Biol. 70:756.
42. 2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28:2714.
43. Chen, W. F., and A. Zlotnik. 1991. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147:528.
44. + cytotoxic T lymphocytes. J. Virol. 74:4729.
45. Comi, C., M. Leone, S. Bonissoni, S. DeFranco, F. Bottarel, C. Mezzatesta, A. Chiocchetti, F. Perla, F. Monaco, and U. Dianzani. 2000. Defective T cell fas function in patients with multiple sclerosis. Neurology 55:921.
46. Shenoy, S., T. Mohanakumar, T. Chatila, J. Tersak, B. Duffy, R. Wang, A. R. Thilenius, and J. H. Russell. 2001. Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias. Clin. Immunol. 99:266.
47. Di Somma, M. M., F. Somma, M. S. Montani, R. Mangiacasale, E. Cundari, and E. Piccolella. 1999. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis. J. Immunol. 162:3851.
48. L underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res. 61:1699.
49. Miossec, C., V. Dutilleul, F. Fassy, and A. Diu-Hercend. 1997. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272:13459.
50. Wilhelm, S., H. Wagner, and G. Hacker. 1998. Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur. J. Immunol. 28:891.
51. Alam, A., L. Y. Cohen, S. Aouad, and R. P. Sekaly. 1999. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190:1879.
52. Kennedy, N. J., T. Kataoka, J. Tschopp, and R. C. Budd. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190:1891.
53. Budd, R. C. 2002. Death receptors couple to both cell proliferation and apoptosis. J. Clin. Invest. 109:437.
54. Zapata, J. M., R. Takahashi, G. S. Salvesen, and J. C. Reed. 1998. Granzyme release and caspase activation in activated human T-lymphocytes. J. Biol. Chem. 273:6916.
55. + T lymphocytes. J. Biol. Chem. 277:32339.
56. Roy, S., C. I. Bayly, Y. Gareau, V. M. Houtzager, S. Kargman, S. L. Keen, K. Rowland, I. M. Seiden, N. A. Thornberry, and D. W. Nicholson. 2001. Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide. Proc. Natl. Acad. Sci. USA 98:6132.
57. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231.
58. Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch, and J. C. Reed. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318.
59. Kane, L. P., V. S. Shapiro, D. Stokoe, and A. Weiss. 1999. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9:601.
60. Madrid, L. V., C. Y. Wang, D. C. Guttridge, A. J. Schottelius, A. S. Baldwin, Jr., and M. W. Mayo. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol. Cell. Biol. 20:1626.
61. Lauder, A., A. Castellanos, and K. Weston. 2001. c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of T cells and is required for PKB-mediated protection from apoptosis. Mol. Cell. Biol. 21:5797.
62. +/- mice. Science 285:2122.
63. Suzuki, A., M. T. Yamaguchi, T. Ohteki, T. Sasaki, T. Kaisho, Y. Kimura, R. Yoshida, A. Wakeham, T. Higuchi, M. Fukumoto, et al. 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14:523.
64. Papoff, G., P. Hausler, A. Eramo, M. G. Pagano, G. Di Leve, A. Signore, and G. Ruberti. 1999. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J. Biol. Chem. 274:38241.
65. Siegel, R. M., J. K. Frederiksen, D. A. Zacharias, F. K. Chan, M. Johnson, D. Lynch, R. Y. Tsien, and M. J. Lenardo. 2000. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288:2354.
66. Sullivan, K. M., R. P. Witherspoon, R. Storb, H. J. Deeg, S. Dahlberg, J. E. Sanders, F. R. Appelbaum, K. C. Doney, P. Weiden, C. Anasetti, et al. 1988. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72:555.
67. Schiller, G., and R. P. Gale. 1993. Is there an effective therapy for chronic graft-versus-host disease? Bone Marrow Transplant. 11:189.